We serve Chemical Name:2-chloro-1-(3-methyl-2,3-dihydroindol-1-yl)ethanone CAS:66624-44-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-chloro-1-(3-methyl-2,3-dihydroindol-1-yl)ethanone
CAS.NO:66624-44-0
Synonyms:1-chloroacetyl-3-methyl-2,3-dihydro-indole
Molecular Formula:C11H12ClNO
Molecular Weight:209.67200
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:20.31000
Exact Mass:209.06100
LogP:2.44050
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-chloroacetyl-3-methyl-2,3-dihydro-indole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-chloroacetyl-3-methyl-2,3-dihydro-indole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-chloroacetyl-3-methyl-2,3-dihydro-indole Use and application,1-chloroacetyl-3-methyl-2,3-dihydro-indole technical grade,usp/ep/jp grade.
Related News: Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives. 2-chloro-1-(3-methyl-2,3-dihydroindol-1-yl)ethanone manufacturer AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said. 2-chloro-1-(3-methyl-2,3-dihydroindol-1-yl)ethanone supplier AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said. 2-chloro-1-(3-methyl-2,3-dihydroindol-1-yl)ethanone vendor AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said. 2-chloro-1-(3-methyl-2,3-dihydroindol-1-yl)ethanone factory During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology.
